AI assistant
Sending…
Monopar Therapeutics — Director's Dealing 2018
Sep 27, 2018
32883_dirs_2018-09-27_86800b4e-aa4f-4046-9df3-e9d00c027d9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Monopar Therapeutics (NONE)
CIK: 0001645469
Period of Report: 2018-08-28
Reporting Person: Tsuchimoto Kim R (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-28 | Stock options | $6 | A | 41100 | Acquired | 2028-08-27 | Common stock (41100) | Direct |
Footnotes
F1: Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter.